Unknown

Dataset Information

0

MiR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.


ABSTRACT:

Background

MicroRNAs (miRs) are involved in cancer carcinogenesis, and certain regulatory miRs could provide promising therapeutic methods for refractory malignancies, such as gallbladder cancer (GBC). miR-223 was found to play a pivotal role in enhancing chemotherapeutic effects, therefore evoking interest in the role of miR-223 in GBC.

Results

miR-223 was decreased in GBC tissues and cell lines, and ectopic miR- 223 expression exhibited multiple anti-tumorigenic effects in GBC cells, including decreased proliferation, migration and invasion in vitro. However, treatment with a miR-223 inhibitor increased cell viability. We determined that STMN1 was negatively correlated with and regulated by miR-223 in GBC. miR-223 increased GBC sensitivity to docetaxel in vitro and in vivo, and the induced sensitivity to docetaxel was suppressed by the restoration of STMN1 expression.

Methods

We examined miR-223 expression in GBC tissue and GBC cell lines using qRT-PCR. The effects of modulated miR-223 expression in GBC cells were assayed using Cell Counting Kit-8 (CCK8), flow cytometry, and wound-healing and invasion assays. Susceptibility to docetaxel was evaluated in miR-223/STMN1-modulated GBC cells and xenograft tumor models. The protein expression of relevant genes was examined by Western blotting.

Conclusions

These findings indicated that miR-223 might serve as an onco-suppressor that enhances susceptibility to docetaxel by downregulating STMN1 in GBC, highlighting its promising therapeutic value.

SUBMITTER: Lu W 

PROVIDER: S-EPMC5308733 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.

Lu Wei W   Hu Yunping Y   Ma Qiang Q   Zhou Linzhu L   Jiang Lin L   Li Zhizhen Z   Zhao Shuai S   Xu Yuzhen Y   Shi Weibin W   Li Sheng S   Liu Yingbin Y  

Oncotarget 20160901 38


<h4>Background</h4>MicroRNAs (miRs) are involved in cancer carcinogenesis, and certain regulatory miRs could provide promising therapeutic methods for refractory malignancies, such as gallbladder cancer (GBC). miR-223 was found to play a pivotal role in enhancing chemotherapeutic effects, therefore evoking interest in the role of miR-223 in GBC.<h4>Results</h4>miR-223 was decreased in GBC tissues and cell lines, and ectopic miR- 223 expression exhibited multiple anti-tumorigenic effects in GBC c  ...[more]

Similar Datasets

| S-EPMC7202487 | biostudies-literature
| S-EPMC6881712 | biostudies-literature
| S-EPMC6366987 | biostudies-literature
| S-EPMC3568119 | biostudies-literature
| S-EPMC3563857 | biostudies-literature
| S-EPMC7110837 | biostudies-literature
| S-EPMC8895464 | biostudies-literature
| S-EPMC10475133 | biostudies-literature
| S-EPMC4931147 | biostudies-literature
| S-EPMC5479025 | biostudies-literature